Allergy, Immunology, and Rheumatology Research
Allergy, Immunology and Rheumatology (AIR) Division researchers are dedicated to elucidating underlying pathways responsible for autoimmune, inflammatory and allergic diseases and translating this to innovative treatments for patients. Individual areas of focus include basic mechanisms of altered bone remodeling in psoriatic and rheumatoid arthritis, inflammation at the bone joint interface in rheumatoid arthritis, basic mechanisms of B cell mediated immunity in SLE and translational studies of the Old Mennonite population to better understand the biologic mechanisms that underlie the low rates of autoimmune and allergic diseases in this population. In addition, the Division has a close working relationship with the Center for Musculoskeletal Research, is a member of the NIH Accelerated Medicines Partnership and is a World Allergy Organization Center of Excellence.

Jennifer Anolik,
MD, PhD
Jennifer Anolik Named Chief of Allergy, Immunology & Rheumatology
A pioneer of autoimmune diseases research, Anolik was named chief of the Allergy, Immunology and Rheumatology Division. She is hitting the ground running, with the introduction of an R38-funded program to expand residents’ research opportunities.
Latest News
January 15, 2025
ROChester Stimulating Access to Research during Residency (ROC StARR) Health and Immune Function Across the Lifespan to Begin July 1st
January 6, 2025
Jennifer Anolik Named Chief of Allergy, Immunology and Rheumatology Division
December 13, 2024
Ilana Abeles Receives Clinical Trial Investigator Award
Looking to Participate in a Clinical Trial?
Learn about our ongoing clinical trials and research studies and how to get involved.

Accelerating Medicines Partnership: Autoimmune and Immune-Mediated Diseases, RA Research Group

Clinical Research Study Coordinators